CoChat

The impact of PKR activation: from neurodegeneration to cancer

Open access
Marchal, Juan A., Lopez, Gabriel J., Peran, Macarena, Comino, Ana, Delgado, Juan R., García‐García, Javier A., Conde, Veronica, Aranda, Fernando M., Rivas, Carmen, Esteban, Mariano, Garcia, Maria A. · 2014 · The FASEB Journal
Cited by 104

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

An inverse association between cancer and neurodegeneration is plausible because these biological processes share several genes and signaling pathways. Whereas uncontrolled cell proliferation and decreased apoptotic cell death governs cancer, excessive apoptosis contributes to neurodegeneration. Protein kinase R (PKR), an interferon‐inducible double‐stranded RNA protein kinase, is involved in both diseases. PKR activation blocks global protein synthesis through eIF2α phosphorylation, leading to cell death in response to a variety of cellular stresses. However, PKR also has the dual role of activating the nuclear factor κ‐B pathway, promoting cell proliferation. Whereas PKR is recognized for its negative effects on neurodegenerative diseases, in part, inducing high level of apoptosis, the role of PKR activation in cancer remains controversial. In general, PKR is considered to have a tumor suppressor function, and some clinical data show a correlation between suppressed or inactivated PKR and a poor prognosis for several cancers. However, other studies show high PKR expression and activation levels in various cancers, suggesting that PKR might contribute to neoplastic progression. Understanding the cellular factors and signals involved in the regulation of PKR in these age‐related diseases is relevant and may have important clinical implications. The present review highlights the current knowledge on the role of PKR in neurodegeneration and cancer, with special emphasis on its regulation and clinical implications.—Marchal, J. A., Lopez, G. J., Peran, M., Comino, A., Delgado, J. R., García‐García, J. A., Conde, V., Aranda, F. M., Rivas, C., Esteban, M., Garcia, M. A. The impact of PKR activation: from neurodegeneration to cancer. FASEB J . 28, 1965–1974 (2014). www.fasebj.org

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fj.13-248294

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 104

Metadata

Authors
Marchal, J. A., Lopez, G. J., Peran, M., Comino, A., Delgado, J. R., García‐García, J. A., Conde, V., Aranda, F. M., Rivas, C., Esteban, M., & Garcia, M. A.
Venue
The FASEB Journal
Publisher
Wiley
Published
2014-02-12
Volume
28
Issue
5
Pages
1965-1974
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W2171156915
Cited by
104
References
17
FWCI
6.53
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.